{"id":12275,"date":"2024-10-12T00:16:14","date_gmt":"2024-10-11T22:16:14","guid":{"rendered":"https:\/\/valintermed.com\/?p=12275"},"modified":"2024-10-12T00:16:14","modified_gmt":"2024-10-11T22:16:14","slug":"rak-mochevogo-puzyrya-bez-invazivnogo-vozdeystviya-na-myshechnyy-sloy","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/bladder-cancer-without-invasive-action-on-the-myocardial-layer\/","title":{"rendered":"Non-muscle-invasive bladder cancer"},"content":{"rendered":"
<\/div>\n

Bladder cancer is a malignancy that begins in the epithelial cells of the bladder. This cancer varies in its aggressiveness, but the main concern is its recurrence and the potential for progression to invasive disease. The most common form is Transitional Cell Carcinoma (TCC), which begins in the transitional cells that line the inside of the bladder. Bladder cancer can present with a variety of symptoms, including gross hematuria, dysuria, and painful urination. It is important to note that many aspects of diagnosis and treatment of this disease are aimed at preventing invasive growth, which is key to maintaining bladder function and the patient's quality of life.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n